Lung cancer often progresses rapidly. Your effective date — the date from which VA calculates back pay — is the date VA receives your claim. Every week of delay is a week of potential $3,700+/month benefits lost. If you cannot file a complete claim today, file an Intent to File (VA Form 21-0966) to lock in today's date while gathering records.
Lung cancer veterans have access to two separate presumptive service connection pathways — one of the few cancer types with this dual coverage. Understanding both and selecting the optimal pathway for your specific service history can affect your effective date and benefit amount.
Lung cancer — classified as a "respiratory cancer" — has been associated with herbicide agent exposure under VA's Agent Orange presumptive framework. The National Academies of Sciences' ongoing research has found sufficient evidence linking Agent Orange exposure to increased lung cancer risk. This pathway covers veterans who served in Agent Orange-designated locations:
The PACT Act of 2022 added lung cancer to its expanded presumptive list for veterans with qualifying toxic exposures at covered locations. Burn pit smoke is a particularly potent respiratory carcinogen — containing polycyclic aromatic hydrocarbons, formaldehyde, benzene, heavy metals, dioxins, and fine particulate matter (PM2.5) that penetrate deep into lung tissue. The PACT Act covers:
For veterans who served in both Vietnam and post-9/11 locations (some senior NCOs and officers), both pathways may apply. Use whichever creates the earliest effective date for your specific claim. For Vietnam-only veterans, the Agent Orange pathway is primary. For post-9/11 veterans without Vietnam service, the PACT Act pathway applies. An accredited attorney can help identify the optimal strategy.
The eligibility requirements are straightforward for both pathways:
Neither pathway requires proof of a specific exposure event, unit assignment near a burn pit, or individual air monitoring data. The service location itself is the qualifying factor.
This is one of the most common concerns veterans and their families have when filing a lung cancer claim — and for PACT Act and Agent Orange presumptive claims, the answer is clear: no, it does not.
The presumptive law eliminates the causation question entirely. VA is not permitted to deny or reduce a presumptive service connection claim based on smoking history, because the law has already determined that the veteran's service caused the cancer. Smoking history is irrelevant to a presumptive claim.
C&P examiners will typically ask about your smoking history as part of the medical examination. Answer honestly — but understand that for a presumptive claim, this information does not determine your eligibility. It may appear in the examiner's report but should not affect the rating decision for a presumptive claim. If a rating decision denies your claim based on smoking history despite a valid presumptive, this is an appealable error.
For veterans filing direct service connection claims (without a presumptive pathway), smoking history becomes more relevant — but a skilled pulmonologist writing a nexus letter can still argue that military toxic exposures materially contributed to or aggravated the lung cancer risk beyond that attributable to smoking alone.
VA rates lung cancer under Diagnostic Code 6819 — "malignant neoplasms of the respiratory system" — in 38 CFR Part 4, Schedule for Rating Disabilities. This DC covers primary lung cancers (non-small cell lung cancer, small cell lung cancer, mesothelioma, and other malignant respiratory tumors).
Lung cancer during active treatment is rated at 100% regardless of stage, histology, or tumor size. Any treatment — surgery, chemotherapy, radiation, targeted therapy, immunotherapy — keeps the rating at 100%.
After treatment ends and the six-month evaluation period passes, VA rates residual pulmonary impairment based on pulmonary function testing (PFT) results. The primary metrics used are:
| FEV1 (% of Predicted) or DLCO (% of Predicted) | VA Rating |
|---|---|
| FEV1 < 40% or DLCO < 40% | 100% |
| FEV1 40–55% or DLCO 40–55% | 60% |
| FEV1 56–70% or DLCO 56–65% | 30% |
| FEV1 71–80% or DLCO 66–80% | 10% |
| FEV1 > 80% and DLCO > 80% | 0% (no rating if controlled and minimally symptomatic) |
VA uses whichever measurement — FEV1 or DLCO — provides the highest rating. This "most favorable basis" rule means that a veteran whose FEV1 is preserved but whose DLCO is impaired (common after lobectomy) should receive the rating based on DLCO rather than FEV1. Ensure your C&P examiner conducts both measurements.
Lung cancer treatment encompasses the full spectrum of modern oncology. All of the following constitute "active treatment" for VA rating purposes:
After the six-month evaluation period, the veteran's residual pulmonary function determines the ongoing rating. Several factors affect how pulmonary function is measured and rated:
Pulmonary function testing for a C&P exam must be performed by a qualified respiratory technician. The effort-dependent nature of PFT testing means that inconsistent effort or an experienced technician encouraging maximum effort both matter significantly. Veterans should:
Even when PFT values are above the minimum threshold for a specific rating, VA must consider dyspnea (shortness of breath) on exertion if it is limiting. Veterans who cannot walk a flat block, cannot climb stairs, or who need to rest frequently due to breathing difficulty should document this functional limitation in detail. A veteran with 80% FEV1 but severe dyspnea on exertion that prevents any meaningful work activity should have their functional impairment evaluated beyond the PFT numbers alone.
Surgical lung resection creates permanent changes to pulmonary anatomy and function. The type of surgery determines the scope of expected residuals:
Lobectomy removes approximately 25–33% of total lung volume (for a right-side procedure with 3 lobes vs. left-side with 2). Most patients experience significant initial pulmonary decline that partially recovers over 3–12 months as remaining lung tissue compensates. The residual impairment depends on baseline pulmonary function, age, and overall health. FEV1 typically drops 10–15% from pre-surgical baseline in healthy patients.
Additional post-lobectomy conditions to claim:
Pneumonectomy is the most radical surgical option and leaves the patient with a single lung. The remaining lung must compensate for the lost tissue, resulting in severe functional limitation:
Non-small cell lung cancer (NSCLC) Stage III-IV and small cell lung cancer (SCLC) typically carry a prognosis measured in months to a few years for most patients. VA recognizes this urgency through terminal illness processing protocols.
To activate terminal illness processing:
If your lung cancer was aggravated, delayed in diagnosis, or worsened due to care at a VA medical center, you may have an additional claim under 38 USC § 1151 for VA hospital negligence. This is separate from the disability presumptive claim and requires legal expertise to navigate — consult with a VA-accredited attorney.
Small cell lung cancer (SCLC) and certain NSCLC cases qualify for Social Security's Compassionate Allowances program, which fast-tracks SSDI review typically to 2–4 weeks. Veterans with lung cancer should file for both VA disability and SSDI simultaneously. These benefits are separate and can be received concurrently.
Speed is essential. Here's the filing process:
If you cannot assemble all documents immediately, file VA Form 21-0966 (Intent to File) online at va.gov today. This locks in today's date as your potential effective date while you gather records. You then have one year to complete the actual claim submission.
List: "Lung cancer — PACT Act presumptive due to toxic exposure during service in [location] [dates]" (or "Agent Orange presumptive under 38 CFR § 3.309(e) due to Vietnam service"). Also list all secondary conditions.
For a lung cancer claim — particularly one involving terminal prognosis, DIC planning for family members, fast-track processing, and complex secondary conditions — VA-accredited attorney representation is strongly recommended. Attorneys who specialize in cancer VA claims can expedite the process, ensure complete claim packages, and maximize the rating across all conditions. Visit claim.vet's attorney marketplace to find one now. You can also start with our free qualification quiz.
Lung cancer is fatal in a significant percentage of diagnosed cases. Veterans whose lung cancer is service-connected entitle their surviving families to Dependency and Indemnity Compensation (DIC) when the veteran dies from that cancer.
Critical DIC planning steps that should happen before the veteran dies:
The DIC base rate for a surviving spouse in 2026 is $1,562.74/month. Additional amounts apply for dependent children, if the surviving spouse is housebound or needs aid and attendance, and if the veteran was 100% rated for 8+ continuous years before death.
Related guides: PACT Act Presumptive Conditions Hub · Agent Orange Presumptive Conditions · Burn Pit Exposure VA Claims · ALS VA Claim: Terminal Illness Benefits.
File Now — Your Effective Date Starts Today
Lung cancer is presumptive — no nexus letter needed. Our free claim review connects you with VA-accredited attorneys who understand cancer claims and can help with fast-track processing.
Check My Lung Cancer Claim — Free →Editorial Standards: Written by Marcus J. Webb, veterans benefits researcher. Verified against 38 CFR § 3.309(e), DC 6819, and PACT Act provisions. Last reviewed: July 2026. Not legal advice — for representation, connect with a VA-accredited attorney.
Lung cancer is presumptive under PACT Act and Agent Orange rules. File now — your effective date is today.
Start My Free Claim Review — No Phone Required →